I liked the part where he say's the Bigger BP's will competitively absorb the smaller Immunotherapy companies! I do like the fact we are mentioned in this article. Funny how it said BP's that have the lead in Immunotherapy will definitely seek for the best combo therapy to advance their drugs. Makes me think BMY might have gotten wind on how well our therapy has been working and wants to take us for a test drive before acquiring us? Trust me BMY is the biggest player in Immunotherapy so them entering the picture isn't surprising to me. In fact that may be the reason Astra told us to take a hike as Dew D. Has implied? He said they the shorts are too smart to be fooled by ADXS? Funny thing is if trials with Astra were not doing well why would BMY even be interested in any collaboration with us? They wouldn't waste there time. Trust me they aren't collaborating with us if we haven't showed great results with Astra or Merck. BMY is way too smart for that! Proof is in the results and BMY stepping up to the plate may be a kink in the game. The more players the more competitive it's going to be! Low ball partnerships and buyout offers double the market cap just isn't going to cut it! Let the games begin survival of the best therapy starts now! Who's going to step up and offer what we're really worth? Amgen stepped up now we're looking for BMY........? If BMY doesn't partner up then I will wonder what's up? That's still a ways away but pressure from outside sources can sure shake up the competition!
awesome article about the general direction of the field of science..now...WHO are the small bios that will be in the wave of buy-outs to occur over these next 5 years??
News 
Market Data 
Discover 
